Epstein Secrets

mercial expertise in medical devces. aognostics. and biologics: leadership roles at ISTO Biologics, Orthofix, Smith & Nephew, Boston Scientific, Johnson & Johnson. and Abbott UPDATED EFTA00810555 u 1 Prostate Cancer - Novel Medicines EFTA00810556 Zuclomiphene: potential to be the first FDA approved dr

49 countries • Manufacturing plant with 100 noon units annual capacity • Public sector represents approx. 90% of revenue (customers include UNFPA, USAID. Brazil, and South Africa( • FC2 business profitable from FY 2006-FY 2017' Global public sector revenues • Base revenue $14 million in FY 2017 •

ned in this Report: Astellas Pharma (ALPMY — NR - $15.00) Eli Lilly (LLY — NR - $78.60) Merck & Co (MRK -NR-$54.54) Pfizer Inc. (PFE -NR-$36.13) Johnson & Johnson. (JNJ -NR-$130.41) 24 EFTA00810599 BROOKLINE CAPITAL MARKETS A Division of CIM Securities Veru, Inc. (VEIV.1)1 April 05, 2018 Important Discl

that made -$14M in revenues in 2017, with -90% of coming from public sector buyers who are stakeholders in public and global healthcare like UNFPA. USAID and Governments of Brazil and South Africa. Manufactured in Kuala Lumpur, Malaysia with a capacity of 100M units/year, FC2 already has and anticipa

ew surge." Although the Times adds "experts aren't sure why vaccination rates have begun falling, or whether vaccine hesitancy, an issue before the Johnson & Johnson pause, is entirely to blame," Lilia Luciano reported on the CBS Weekend NewsVi (4/25, lead story, 2:30, Duncan, 1.24M) that a new CBS News poll "fin

id-19 vaccines by the end of 2022," and USA Today (4/25, Bacon, Culver, Ortiz, 12.7M) reports that the Administration is deploying a team of CDC and USAID experts to assist India. Reuters (4/25, Shalal) reports Rep. Ro Khanna (D-CA), the Congressional India Caucus Vice Chair, "welcomed the announceme

8dd-3(a). @ Section 30A(a)(3) of the Exchange Act, 15 U.S.C. § 78dd-1 (a) (3); 15 US.C. §§ 78dd-2(a) (3), 78dd-3(a)(3). BI See, CL5 Complaint, SEC v. Johnson & Johnson, No. 11-cv-686 (D.D.C. Apr. 8, 2011) [hereinafter SEC v. Johnson & Johnson| (bribes paid through Greek and Romanian agents)), available at http: //ww

f efficiency and puts pressure on ethical enterprises to lower their standards or risk losing business. Td. 3 See, e.g, U.S. AGENCY FOR INT'L Dev., USAID ANTICORRUPTION STRATEGY 5-6 (2005), available at http://transition.usaid.gov/policy/ ads/200/200mbo.pdf. The growing recognition that corruption pose